Description
Complete Handbook on Novorapid Penfill (3ml Each)
| Medicine |
Novorapid Penfill (3ml Each) |
| Marketed By | Novo Nordisk India Pvt Ltd |
| Active Ingredient | Insulin Aspart (100IU) |
| Storage | Store in a refrigerator (2 – 8°C). Do not freeze. |
| Consume Type | Injectable |
Novorapid Penfill (3ml Each) – Introduction
Novorapid Penfill (3ml Each) manages blood sugar levels in individuals with type 1 and type 2 diabetes mellitus. This rapid-acting insulin effectively lowers blood sugar levels following meals, minimizing the risk of severe diabetes-related complications.
How Novorapid Penfill (3ml Each) Works: A Closer Look
Novorapid Insulin Penfill (3ml Each) is a swift-acting insulin that initiates its effects within 10-20 minutes post-injection. Operating similarly to the body’s natural insulin, it aids in the reabsorption of glucose by muscles and fat cells while inhibiting the release of glucose from the liver.
Novorapid Penfill (3ml Each) Use
Treatment of Diabetes
Novorapid Penfill (3ml Each) – The Benefits
Novorapid Penfill Cartridges is a contemporary, rapid-acting insulin designed to regulate elevated blood glucose levels effectively. Serving as a substitute for naturally produced insulin in the body, it facilitates the entry of glucose into cells for energy utilization. The onset of action occurs within 10-20 minutes post-injection, and its impact can endure for 3-5 hours. Mastery of the precise techniques, locations, and timing for administering this medication is crucial for optimal effectiveness.
Maintaining lower blood glucose levels is instrumental in mitigating the risk of severe diabetes-related complications, including kidney damage, eye issues, nerve complications, and limb loss. Incorporating this medication into your routine, coupled with a balanced diet and regular exercise, is pivotal for leading an everyday and healthy life.
Novorapid Penfill (3ml Each) – A Usage Guide
Your doctor or nurse will explain how to use this medication.
Novorapid Penfill (3ml Each) – Side Effects
Most adverse effects disappear when your body gets used to the medication and doesn’t require medical attention. See your physician if they continue or if you have concerns about them.
Common Side Effects
- Hypoglycemia (low blood glucose level)
- Headache
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
[Note: Different drugs can cause varying side effects. To get accurate information about a medication’s specific side effects, refer to the official prescribing information for that medication or consult with your healthcare provider.]
Novorapid Penfill (3ml Each) – A Guide to Safety
Alcohol
Unsafe
Drinking alcohol while using Novorapid Penfill (3ml Each) is not recommended.
Pregnancy
Safe If Prescribed
Novorapid Insulin Penfill is commonly considered safe during pregnancy. Studies conducted on animals indicate minimal or no harmful effects on the developing baby. Nonetheless, extensive human studies are scarce on this matter.
Breast feeding
Safe If Prescribed
Novorapid Penfill (3ml Each) is considered safe for use during breastfeeding. Research involving humans indicates that the medication does not transfer in substantial quantities to breast milk, posing no significant harm to the nursing baby.
Driving
Caution
Your vehicle capacity may be compromised by excessively low or high blood sugar levels. Avoid driving if you experience these symptoms.
Liver
Caution
Exercise caution when using Novorapid Penfill (3ml Each) in individuals with liver disease, as dosage adjustments may be necessary. It is recommended that you consult your doctor in this regard. Regular and frequent monitoring of blood glucose levels is also advised.
Kidney
Caution
Exercise caution when administering Novorapid Insulin Penfill to patients with kidney disease, as adjustments to the dosage may be necessary. It is advisable to consult your doctor for guidance. Regular monitoring of blood glucose levels is also recommended to facilitate appropriate dose adjustments.
Fact Box
| Chemical Group | Peptide Hormone |
| Addictive | No |
| Medication Class | Insulin analogues- rapid-acting |
| Action Class/Category | Anti-Diabetic |
Swift Advice
- Novorapid Penfill (3ml Each) aids in managing blood sugar levels to prevent long-term complications.
- Administer the injection 15 minutes before or within 20 minutes after initiating a meal.
- Hypoglycemia (low blood sugar) is a common side effect, necessitating regular blood sugar level monitoring.
- Carry sugary food or fruit juice at all times to address hypoglycemia symptoms like cold sweats, pale skin, tremors, weakness, and anxiety.
- Subcutaneous injections in the abdominal area lead to quicker absorption than other sites.
- Rotate injection sites to prevent the development of hard lumps at a single location.
- Opened vials/cartridges remain viable at room temperature for up to 4 weeks, while unopened ones require refrigeration (2°C–8°C).
- Do not use the medication if the preparation is no longer clear, colorless, or contains particles.
What category of drugs does Novorapid Penfill (3ml Each) fall under?
Novorapid Penfill (3ml Each) is an antidiabetic medication that falls under the category of insulin analogs. It is recommended for diabetic adults and children aged two years and older. The primary purpose of this medication is to enhance blood sugar levels and achieve better glycemic control.
Does Novorapid Penfill make you gain weight?
Yes, Novorapid Penfill (3ml Each) is associated with weight gain, whether used independently or combined with other insulin treatments. This increase in body weight is prevalent and primarily attributed to reduced glucose excretion through urine. Another contributing factor is the anabolic effects of insulin, which promote the formation of fat and proteins. For precise insights into the reasons behind weight gain and suitable solutions, it is advisable to consult with your healthcare provider.
What are the storage requirements for Novorapid Penfill?
NovoRapid Penfill should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) but can be kept at room temperature (below 30°C or 86°F) for up to 28 days once in use.
How should Novorapid Penfill be given?
Novorapid Penfill should be administered subcutaneously according to the prescribed dose, following proper injection technique and site rotation for optimal absorption.
Who is the best Novorapid Penfill wholesale distributor?
The Lotus Biotech stands out as a leading wholesale distributor of Novorapid Penfill, offering reliable supply and competitive pricing. Contact us at info@thelotusbiotech.com or +91 98998 96668 for superior service and quality products.
